AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026Net buying: insiders sold $0 and bought $21K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$21K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 2- Open
- $1.13
- 52-wk high
- $6.88
- High
- $1.15
- 52-wk low
- $0.90
- Low
- $1.09
- Prev close
- $1.11
- Mkt cap
- $187.3M
- Volume
- 3.29M
- Beta
- 0.84
- P/S
- 269.3x
- P/B
- 1.3x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -56.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CMPX filings
Are insiders buying or selling Compass Therapeutics Inc. (CMPX) stock?
Net buying: insiders sold $0 and bought $21K of CMPX stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. The largest was Lerner, Neil (Chief Accounting Officer), who bought $21K. The latest filing was on Oct 2, 2026.
Which members of Congress have traded CMPX recently?
None. No member of Congress disclosed a CMPX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CMPX smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (2)
- LN
Lerner Neil
$18K
bought
- LN
Lerner Neil
$3K
bought
How top traders are positioned
No tracked top-trader positions in CMPX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 20.0% below what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.11 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.13 / -$0.11Yahoo Finance | -20.00% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | -$0.10 / -$0.10Yahoo Finance | +0.00% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 5, 2026 | -$0.09 / -$0.09Yahoo Finance | -$0.00 miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | -$0.08 / -$0.13Yahoo Finance | +39.62% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 11, 2025 | -$0.14 / -$0.12Alpha Vantage | -16.67% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.12 / -$0.11Alpha Vantage | -9.09% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$0.11 / -$0.10Alpha Vantage | -10.00% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.08 / -$0.11Alpha Vantage | +27.27% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 4, 2026, in 33 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $187M
Valuation
- P/S269.28
- P/B1.27
Quality
- Operating margin0.0%
- ROE-56.7%
- ROA-33.0%
Growth
- Beta0.84
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace